학술논문
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer
Document Type
Article
Author
Source
In: Advances in Radiation Oncology . (Advances in Radiation Oncology, 1 March 2022, 7(2))
Subject
Language
English
ISSN
24521094